Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-004805-17Phase 2Completed
Phase 2 trial of cadazolid in Clostridioides difficile colitis (CDI) (2 arms), sponsored by Actelion Pharmaceuticals Ltd. Primary endpoints: Safety and pharmacokinetics of cadazolid (Part A) and Efficacy of cadazolid (Part A). Started Apr 2017; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-004805-17.